Cellectar Biosciences ROA 2010-2025 | CLRB
Current and historical return on assets (ROA) values for Cellectar Biosciences (CLRB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Cellectar Biosciences ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $-0.03B | $0.02B | -93.46% |
| 2024-12-31 | $-0.05B | $0.03B | -134.33% |
| 2024-09-30 | $-0.05B | $0.04B | -168.60% |
| 2024-06-30 | $-0.05B | $0.03B | -203.77% |
| 2024-03-31 | $-0.06B | $0.04B | -300.00% |
| 2023-12-31 | $-0.04B | $0.01B | -307.14% |
| 2023-09-30 | $-0.05B | $0.02B | -272.73% |
| 2023-06-30 | $-0.04B | $0.01B | -222.22% |
| 2023-03-31 | $-0.03B | $0.02B | -156.10% |
| 2022-12-31 | $-0.03B | $0.02B | -125.25% |
| 2022-09-30 | $-0.03B | $0.02B | -94.74% |
| 2022-06-30 | $-0.03B | $0.03B | -72.99% |
| 2022-03-31 | $-0.02B | $0.03B | -60.38% |
| 2021-12-31 | $-0.02B | $0.04B | -52.75% |
| 2021-09-30 | $-0.02B | $0.04B | -43.14% |
| 2021-06-30 | $-0.02B | $0.05B | -43.72% |
| 2021-03-31 | $-0.02B | $0.06B | -45.28% |
| 2020-12-31 | $-0.02B | $0.06B | -56.64% |
| 2020-09-30 | $-0.02B | $0.02B | -90.91% |
| 2020-06-30 | $-0.02B | $0.02B | -98.36% |
| 2020-03-31 | $-0.01B | $0.01B | -100.00% |
| 2019-12-31 | $-0.01B | $0.01B | -93.33% |
| 2019-09-30 | $-0.02B | $0.02B | -95.24% |
| 2019-06-30 | $-0.02B | $0.02B | -95.52% |
| 2019-03-31 | $-0.02B | $0.01B | -116.36% |
| 2018-12-31 | $-0.02B | $0.02B | -115.38% |
| 2018-09-30 | $-0.02B | $0.02B | -136.00% |
| 2018-06-30 | $-0.02B | $0.01B | -150.00% |
| 2018-03-31 | $-0.02B | $0.01B | -130.43% |
| 2017-12-31 | $-0.02B | $0.01B | -117.65% |
| 2017-09-30 | $-0.02B | $0.01B | -113.21% |
| 2017-06-30 | $-0.01B | $0.01B | -107.69% |
| 2017-03-31 | $-0.01B | $0.02B | -104.00% |
| 2016-12-31 | $-0.01B | $0.02B | -87.80% |
| 2016-09-30 | $0.00B | $0.01B | -23.53% |
| 2016-06-30 | $0.00B | $0.01B | -25.81% |
| 2016-03-31 | $0.00B | $0.01B | -27.59% |
| 2015-12-31 | $-0.01B | $0.01B | -58.82% |
| 2015-09-30 | $-0.01B | $0.01B | -92.31% |
| 2015-06-30 | $-0.01B | $0.01B | -57.14% |
| 2015-03-31 | $-0.01B | $0.01B | -60.87% |
| 2014-12-31 | $-0.01B | $0.01B | -74.42% |
| 2014-09-30 | $-0.01B | $0.02B | -97.30% |
| 2014-06-30 | $-0.01B | $0.01B | -129.03% |
| 2014-03-31 | $-0.01B | $0.01B | -108.11% |
| 2013-12-31 | $-0.01B | $0.01B | -93.02% |
| 2013-09-30 | $-0.01B | $0.01B | -68.09% |
| 2013-06-30 | $-0.01B | $0.01B | -85.11% |
| 2013-03-31 | $-0.01B | $0.01B | -85.11% |
| 2012-12-31 | $-0.01B | $0.01B | -85.71% |
| 2012-09-30 | $-0.01B | $0.01B | -85.71% |
| 2012-06-30 | $-0.01B | $0.01B | -82.05% |
| 2012-03-31 | $-0.01B | $0.01B | -102.86% |
| 2011-12-31 | $-0.01B | $0.01B | -118.52% |
| 2011-09-30 | $-0.01B | $0.01B | -114.29% |
| 2011-06-30 | $-0.01B | $0.01B | -117.65% |
| 2011-03-31 | $0.00B | $0.00B | -123.08% |
| 2010-12-31 | $0.00B | $0.01B | 44.44% |
| 2010-09-30 | $-0.01B | $0.00B | -200.00% |
| 2010-06-30 | $-0.01B | $0.00B | -208.00% |
| 2010-03-31 | $-0.02B | $0.01B | -246.15% |
| 2009-12-31 | $-0.02B | $0.01B | -340.74% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.018B | $0.000B |
| Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $240.237B | 28.89 |
| Boston Scientific (BSX) | United States | $154.040B | 38.56 |
| Stryker (SYK) | United States | $147.507B | 30.84 |
| EssilorLuxottica (ESLOY) | France | $130.320B | 0.00 |
| Medtronic (MDT) | Ireland | $110.401B | 15.65 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.194B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.171B | 26.90 |
| ResMed (RMD) | United States | $37.523B | 28.18 |
| Agilent Technologies (A) | United States | $33.417B | 21.78 |
| GE HealthCare Technologies (GEHC) | United States | $32.959B | 15.65 |
| Terumo (TRUMY) | Japan | $27.294B | 35.45 |
| Koninklijke Philips (PHG) | Netherlands | $23.014B | 16.15 |
| Insulet (PODD) | United States | $21.880B | 85.88 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.269B | 11.73 |
| Baxter (BAX) | United States | $15.698B | 11.72 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.073B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.474B | 22.53 |
| Lantheus Holdings (LNTH) | United States | $5.601B | 14.13 |
| Prestige Consumer Healthcare (PBH) | United States | $4.184B | 18.69 |
| Perrigo (PRGO) | Ireland | $3.678B | 9.32 |
| Haemonetics (HAE) | United States | $3.510B | 15.99 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.221B | 23.75 |
| Envista Holdings (NVST) | United States | $3.210B | 26.68 |
| GN Store Nord (GNNDY) | Denmark | $2.346B | 19.43 |
| QuidelOrtho (QDEL) | United States | $1.939B | 13.34 |
| LeMaitre Vascular (LMAT) | United States | $1.916B | 42.83 |
| AtriCure (ATRC) | United States | $1.621B | 0.00 |
| Acuren (TIC) | United States | $1.311B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.182B | 12.00 |
| Neogen (NEOG) | United States | $1.070B | 13.69 |
| Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
| BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.004B | 12.83 |
| Kestra Medical Technologies (KMTS) | United States | $0.906B | 0.00 |
| InMode (INMD) | Israel | $0.870B | 8.76 |
| CeriBell (CBLL) | United States | $0.710B | 0.00 |
| Evolus (EOLS) | United States | $0.620B | 0.00 |
| Owens & Minor (OMI) | United States | $0.578B | 4.79 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.568B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.519B | 0.00 |
| Valneva SE (VALN) | France | $0.477B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.423B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.384B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.328B | 12.05 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.300B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.279B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.10 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| ZimVie (ZIMV) | United States | $0.247B | 11.22 |
| Brainsway (BWAY) | Israel | $0.232B | 61.30 |
| Canopy Growth (CGC) | Canada | $0.230B | 0.00 |
| Quanterix (QTRX) | United States | $0.229B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.224B | 66.33 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| Omeros (OMER) | United States | $0.198B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.182B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.74 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.131B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.121B | 14.84 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| Veru (VERU) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.32 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| MacroGenics (MGNX) | United States | $0.085B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 59.43 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.89 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| INLIF (INLF) | $0.014B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |